Multilevel obstacles to heart-healthy living in the context of Ischemic heart disease: A qualitative study

Bardia Amidi1,2, Narges Naderi1, Javad Yoosefi Lebni3

  • 1Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.

Plos One
|December 9, 2025
PubMed

Insights

Barriers to healthy lifestyles for ischemic heart disease (IHD) patients in Iran include sociocultural, economic, individual, and healthcare system challenges. Addressing these requires community programs, financial aid, and improved patient education for better health outcomes.

Area of Science:

  • Cardiology and Public Health
  • Qualitative Research Methods

Background:

  • Ischemic heart disease (IHD) is a leading cause of death globally.
  • Lifestyle modifications are crucial for IHD prevention and management.
  • Patients with IHD encounter significant obstacles in adopting healthy behaviors.

Purpose of the Study:

  • To explore the barriers to lifestyle modifications among patients with ischemic heart disease (IHD).
  • To identify sociocultural, economic, individual, and healthcare-related challenges faced by IHD patients in Lorestan Province, Iran.

Main Methods:

  • A qualitative conventional content analysis approach was employed.
  • Semi-structured interviews were conducted with 31 IHD patients and 8 key informants.
  • Data were analyzed using MAXQDA-2020, adhering to the Granheim and Lundman approach and Guba and Lincoln's criteria for trustworthiness.

Main Results:

  • Four primary categories of barriers were identified: sociocultural, economic, individual, and healthcare-medical.
  • Specific barriers include health-related taboos, economic crises, low health literacy, and communication gaps within the healthcare system.
  • These interconnected barriers significantly impede IHD patients' ability to adopt and maintain healthy lifestyles.

Conclusions:

  • Multifaceted barriers (sociocultural, economic, individual, healthcare) hinder lifestyle changes in IHD patients.
  • Effective interventions require community engagement, financial support, tailored education, and health system reforms.
  • Further research should assess the feasibility of interventions to improve long-term IHD patient outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
575
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
342
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
850
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
307